Oesophagogastric junction adenocarcinoma related biomarker and application thereof
A technology for gastric junction adenocarcinoma and esophagogastric cancer, applied in the field of NFIB, can solve the problems of unreported function
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0037] specific implementation
[0038] The present invention studies the clinicopathological data of patients with esophagogastric junction adenocarcinoma who have received surgical treatment, and uses immunohistochemistry (IHC) in the immunoassay method to detect the expression of NFI transcription factor in cancer tissues and paracancerous tissues The relationship between the expression of NFI transcription factors and clinical case factors such as clinical stage, degree of tumor differentiation and lymph node metastasis in patients with esophagogastric junction adenocarcinoma was analyzed, and the Cox proportional hazard regression model was constructed to further analyze the role of NFI transcription factors in predicting esophagogastric junction adenocarcinoma. The prognostic significance of junctional adenocarcinoma provides an important theoretical basis for the diagnosis and prognosis of esophagogastric junction adenocarcinoma.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com